Filters
reset allResults: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PathGroup United States | 3 | 4 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay PathGroup United States | 16 | 65 |
|
Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis PathGroup United States | 16 | 65 |
|
Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR PathGroup United States | 16 | 65 |
|
Comprehensive HemeComplete Profile with IGH Somatic Hypermutation PathGroup United States | 13 | 161 |
|
PathGroup United States | 23 | 160 |
|
PathGroup United States | 18 | 160 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS PathGroup United States | 17 | 160 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 PathGroup United States | 17 | 160 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.